# Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

> **NCT00368537** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 550 (actual)

## Conditions studied

- Skin Diseases, Bacterial

## Interventions

- **DRUG:** Tigecycline
- **DRUG:** ampicillin-sulbactam

## Key facts

- **NCT ID:** NCT00368537
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2012-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368537, "Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00368537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*